Discussion on: Efficacy and Safety of Adjuvant Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Post-Reception: A Meta-analysis

Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.

Article Title

Efficacy and Safety of Adjuvant Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Post-Reception: A Meta-analysis

Authored by

Nadeem Ashraf
Department of Hepatopancreatobiliary, Zhongnan Hospital of Wuhan University, Hubei, Wuhan, China.

Wajahat Akram
Department of Internal Medicine, Habeeb Medical Complex, Ha’il 55424, Saudi Arabia.

Kun Li
Department of Hepatopancreatobiliary, Zhongnan Hospital of Wuhan University, Hubei, Wuhan, China.

DOI or Article Link

https://doi.org/10.9734/irjgh/2025/v8i1122

Leave a Comment